期刊文献+

离子色谱-脉冲安培电化学检测引流组织液中的妥布霉素 被引量:7

Analysis of Tobramycin in Human Drainage Tissue Fluid by Ion Chromatography with Pulsed Integrated Amperometric Detection
下载PDF
导出
摘要 建立了一种离子色谱(IC)分离,脉冲安培电化学法(PAD)直接检测人体引流组织液中妥布霉素的分析方法。采用高交换容量阴离子交换柱和低浓度KOH在线淋洗分离,不需要采用衍生化和离子对-柱后加碱等实现分离,并可在短时间内完成妥布霉素的测定。采用本方法测定的妥布霉素线性范围为0.05~10mg/L,线性相关系数为0.9997,保留时间、峰面积和峰高的相对标准偏差分别为0.14%,0.38%和0.81%,检出限为7.11-g/L。本方法成功应用于骨髓炎患者引流组织液中妥布霉素的测定,样品实际加标回收率为100.8%。 A new method was developed for the separation and determination of tobramycin in human drainage tissue fluid by ion chromatography(IC) with pulsed integrated amperometric detection(PAD).Tobramycin was separated on an anion-exchange column of high capacity using a weak potassium hydroxide solution as eluent.In comparison with the previous methods,derivatization and ion-pairing with post-column addition of NaOH were not required in this method.Under the optimum conditions,the linear range of the calibration curve for tobramycin was 0.05-10 mg/L(r=0.9997),whereas detection limit was 7.11 μg/L(S/N=3).The spiked recovery was 100.8% and the relative standard deviations for retention time,peak area and peak height were 0.14%,0.38% and 0.81% respectively.The method was successfully applied to determine tobramycin in human drainage tissue fluid of patient who suffered from traumatic osteomyelitis.
出处 《分析化学》 SCIE EI CAS CSCD 北大核心 2012年第6期960-963,共4页 Chinese Journal of Analytical Chemistry
基金 科技厅科技计划(No.2011C23044)资助项目
关键词 离子色谱 脉冲安培电化学检测 妥布霉素 引流组织液 Ion chromatography; Integrated pulsed amperometric detection; Tobramycin; Drainage tissue fluid
  • 相关文献

参考文献19

  • 1Stead D A. J. Chromatogr. B, 2000, 747(1-2) : 69-93.
  • 2Valoran P H, Jeffrey S R. Journal of Pharmaceutical and Biomedical Analysis, 2006, 40(4): 1006-1012.
  • 3Sachetelli S, Beaulac C, Lagace J. Biochimicaet Biophysica Acta general subjects, 1998, 1379(1): 35-41.
  • 4Banerjee S K, Wells A, Dasgupta A. Therapeutic Drug Monitoring, 1999, 21(5): 540-543.
  • 5White L O, Holt H A, Reeves D S, MacGowan A P. J. Antimicrob. Chemother, 1997, 39(3) : 355-361.
  • 6Touw D J, de Graaf A I, de Goede P. Therapeutic Drug Monitoring, 1996, 18(2) : 189-193.
  • 7Sampath S S, Robinson D H. J. Pharm. Sci. , 1990, 79(5): 428-431.
  • 8Fujita Y, Mori I, Kitano S. Chem. Pharm. Bull. , 1984, 32(3):1214-1218.
  • 9Dasgupta V, Stewart K R, Gunter J M. J. Pharm. Sci., 1983, 72(12): 1470-1471.
  • 10Kabra P M, Bhatnagar P K, Nelson M A, Wall J H, Marton L J. Clin. Chem. , 1983, 29(4): 672-674.

同被引文献148

引证文献7

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部